000 | 03262nam a2200397 i 4500 | ||
---|---|---|---|
001 | CR9781009099615 | ||
003 | UkCbUP | ||
005 | 20240807190747.0 | ||
006 | m|||||o||d|||||||| | ||
007 | cr|||||||||||| | ||
008 | 210505s2023||||enk o ||1 0|eng|d | ||
020 | _a9781009099615 (ebook) | ||
020 | _z9781316515204 (hardback) | ||
020 | _z9781009096492 (paperback) | ||
040 |
_aUkCbUP _beng _erda _cUkCbUP |
||
043 | _an-us--- | ||
050 | 4 |
_aRA410.53 _b.A44 2023 |
|
082 | 0 | 4 |
_a338.4736210973 _223 |
100 | 1 |
_aAngerhofer, Tirza J., _eauthor. |
|
245 | 1 | 0 |
_aAntitrust policy in health care markets / _cTirza J. Angerhofer, Roger D. Blair, Christine Piette Durrance. |
264 | 1 |
_aCambridge, United Kingdom ; New York, NY : _bCambridge University Press, _c2023. |
|
300 |
_a1 online resource (xxv, 502 pages) : _bdigital, PDF file(s). |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
500 | _aTitle from publisher's bibliographic system (viewed on 24 Nov 2022). | ||
505 | 0 | _aHealth Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy. | |
520 | _aHealth care costs in the United States are much higher than in other countries. These cost differences can be explained in part by a lack of competition in the United States. Some markets, such as pharmaceuticals and medical equipment, have elements of monopoly. Other markets, such as health insurance, have elements of monopsony. Many other markets may be subject to collusion on prices, such as generic drugs, or wages, such as the nurse labor market. Lawful monopoly and monopsony are beyond the reach of antitrust laws, but collusion is not. When appropriate, vigorous antitrust enforcement challenging anticompetitive conduct can aid in reducing health care costs. This book addresses monopoly, monopsony, cartels of sellers and buyers, horizontal and vertical merger policy, and antitrust enforcement through private suits as well as the efforts of the antitrust Agencies. The authors demonstrate how enforcing antitrust laws can ultimately promote competition and reduce health care costs. | ||
650 | 0 |
_aMedical economics _zUnited States. |
|
650 | 0 |
_aAntitrust law _zUnited States. |
|
700 | 1 |
_aBlair, Roger D., _eauthor. |
|
700 | 1 |
_aDurrance, Christine Piette, _eauthor. |
|
776 | 0 | 8 |
_iPrint version: _z9781316515204 |
856 | 4 | 0 | _uhttps://doi.org/10.1017/9781009099615 |
942 |
_2ddc _cEB |
||
999 |
_c9115 _d9115 |